TR201910896T4 - Özgün 6,7-dihidro-3H-oksazolo[3,4-A]pirazin-5,8-dion türevi bileşikler. - Google Patents

Özgün 6,7-dihidro-3H-oksazolo[3,4-A]pirazin-5,8-dion türevi bileşikler. Download PDF

Info

Publication number
TR201910896T4
TR201910896T4 TR2019/10896T TR201910896T TR201910896T4 TR 201910896 T4 TR201910896 T4 TR 201910896T4 TR 2019/10896 T TR2019/10896 T TR 2019/10896T TR 201910896 T TR201910896 T TR 201910896T TR 201910896 T4 TR201910896 T4 TR 201910896T4
Authority
TR
Turkey
Prior art keywords
oxazolo
pyrazine
dihydro
unique
derivative compounds
Prior art date
Application number
TR2019/10896T
Other languages
English (en)
Inventor
Luiz Sacurai Sérgio
Eduardo Da Costa Touzarim Carlos
Travanca Toledo Fabiano
Artur De Sousa Bruno
Original Assignee
Biolab Sanus Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolab Sanus Farmaceutica Ltda filed Critical Biolab Sanus Farmaceutica Ltda
Publication of TR201910896T4 publication Critical patent/TR201910896T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

Mevcut buluş 6,7-dihidro-3H-oksazolo[3,4-a]pirazin-5,8-dion bileşiğinin özgün türevleriyle ve bunların farmasötik olarak kabul edilebilir tuzlarıyla; bunların, ayrı biçimlerinde ve/veya herhangi bir oranda enantiyomerik fazlalarıyla rasemik veya rasemik olmayan karışımlar biçimindeki enantiyomerleri ve/veya diastereoizomerleriyle; bahsedilen bileşikler ve/veya bunların türevlerinin hazırlanma prosesleriyle ilgilidir.
TR2019/10896T 2014-02-24 2015-02-24 Özgün 6,7-dihidro-3H-oksazolo[3,4-A]pirazin-5,8-dion türevi bileşikler. TR201910896T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461943825P 2014-02-24 2014-02-24

Publications (1)

Publication Number Publication Date
TR201910896T4 true TR201910896T4 (tr) 2019-08-21

Family

ID=53877456

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/10896T TR201910896T4 (tr) 2014-02-24 2015-02-24 Özgün 6,7-dihidro-3H-oksazolo[3,4-A]pirazin-5,8-dion türevi bileşikler.

Country Status (19)

Country Link
US (1) US9359378B2 (tr)
EP (1) EP3133072B1 (tr)
JP (1) JP6636463B2 (tr)
KR (1) KR102408431B1 (tr)
AR (1) AR099523A1 (tr)
AU (1) AU2015221431B2 (tr)
BR (1) BR112016019609B1 (tr)
CA (1) CA2940225C (tr)
CL (1) CL2016002125A1 (tr)
ES (1) ES2734063T3 (tr)
HU (1) HUE044993T2 (tr)
IL (1) IL247330B (tr)
MX (1) MX369840B (tr)
PL (1) PL3133072T3 (tr)
PT (1) PT3133072T (tr)
TR (1) TR201910896T4 (tr)
UY (1) UY36010A (tr)
WO (1) WO2015123748A1 (tr)
ZA (1) ZA201606522B (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3144770A1 (en) * 2019-07-15 2021-01-21 Biolab Sanus Farmaceutica Ltda Stereoisomers of the compound 3-(benzo[d][1,3]dioxol-5-yl)-7-(1-hydroxypropan-2-yl)-1-(1h-indol-3-yl)-6,7-dihydro-3h-oxazol[3,4-a]pyrazine-5,8-dione and use thereof as an antitumor agent and phosphodiesterase enzyme inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002098877A1 (en) * 2001-06-05 2002-12-12 Lilly Icos Llc Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives
AR045950A1 (es) * 2003-10-09 2005-11-16 Speedel Experimenta Ag Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
AR073522A1 (es) * 2008-09-30 2010-11-10 Biolab Sanus Farmaceutica Ltda Compuestos derivados de 2-(3-metilenodioxi) - benzoil indol
BRPI0903803B1 (pt) * 2009-09-30 2019-07-09 Biolab Sanus Farmacêutica Ltda. Composto, processo de preparação, composição farmacêutica e uso dos compostos
UY33535A (es) * 2010-08-13 2011-12-01 Biolab Sanus Farmaceutuca Limitada Derivados de 6,7-dihidro-3h-oxazolo[3,4]pirazin-5,8-diona

Also Published As

Publication number Publication date
CA2940225C (en) 2021-12-28
KR102408431B1 (ko) 2022-06-13
BR112016019609B1 (pt) 2022-06-14
ZA201606522B (en) 2018-04-25
WO2015123748A1 (pt) 2015-08-27
US9359378B2 (en) 2016-06-07
US20150239903A1 (en) 2015-08-27
IL247330A0 (en) 2016-09-29
AU2015221431A8 (en) 2016-11-24
AU2015221431A1 (en) 2016-09-29
EP3133072A4 (en) 2017-08-09
AR099523A1 (es) 2016-07-27
PL3133072T3 (pl) 2019-10-31
EP3133072A1 (en) 2017-02-22
CA2940225A1 (en) 2015-08-27
JP6636463B2 (ja) 2020-01-29
PT3133072T (pt) 2019-07-26
AU2015221431B2 (en) 2018-04-19
BR112016019609A2 (tr) 2017-08-22
IL247330B (en) 2020-10-29
UY36010A (es) 2015-09-30
MX369840B (es) 2019-11-22
CL2016002125A1 (es) 2016-12-30
MX2016010912A (es) 2016-11-30
JP2017506263A (ja) 2017-03-02
HUE044993T2 (hu) 2019-11-28
KR20160116028A (ko) 2016-10-06
ES2734063T3 (es) 2019-12-04
EP3133072B1 (en) 2019-05-01

Similar Documents

Publication Publication Date Title
SA519401180B1 (ar) مركبات بيروليزين بها استبدال واستخداماتها
PH12018502102A1 (en) Pyrrolotriazine compounds as tam inhibitors
UY36544A (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona
CR20170237A (es) Nuevos compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-diona 3-sustituidos para el tratamiento y profilaxis de infecciones virales.
CL2016001895A1 (es) Compuestos
NI201800128A (es) Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos
EP3389783A4 (en) NOVEL COMPOUNDS THAN INDOLAMINE-2,3-DIOXYGENASE INHIBITORS
MD20170016A2 (ro) Compuşi aminopirimidinici ca inhibitori JAK
UY36564A (es) Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos
CL2019001066A1 (es) Sal de (s)-csa de s-ketamina, sal de (r)-csa de s-ketamina y procesos para la preparación de s-ketamina (divisional solicitud 201702854)
EA201600622A1 (ru) Бициклические анелированные гетероарильные или арильные соединения и их применение в качестве ингибиторов irak4
CY1124076T1 (el) Ημιθειικο αλας του 5,10-μεθυλενο-(6r)-τετραϋδροφυλλικου οξεος
EA201891251A1 (ru) Бициклические ингибиторы pad4
CR20170008A (es) Compuestos de [1,2,4] triazol e imidazol sustituidos
GT201700190A (es) Desacetoxitubulisina h y análogos de esta
EA201790627A1 (ru) СТИМУЛЯТОРЫ рГЦ
EP3504185A4 (en) NEW SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE (IDO)
EA201890626A1 (ru) ЗАМЕЩЕННЫЕ 1,2-ДИГИДРО-3H-ПИРРОЛО[1,2-c]ИМИДАЗОЛ-3-ОНОВЫЕ АНТИБАКТЕРИАЛЬНЫЕ СОЕДИНЕНИЯ
MX370253B (es) Composiciones de compuestos de jasmonato y métodos de uso de las mismas.
EA202090620A1 (ru) Энантиомеры замещенных тиазолов в качестве противовирусных соединений
MX2017016619A (es) Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos.
BR112017000730A2 (pt) derivados de pirrolidinona como inibidores de metap-2
EP3448522A4 (en) NOVEL SUBSTITUTED IMIDAZOPYRIDIN COMPOUNDS AS INHIBITORS OF INDOLAMINE-2,3-DIOXYGENASE AND / OR TRYPTOPHANE-2,3-DIOXYGENASE
EA201691412A1 (ru) Гидроксиформамидные производные и их применение
CY1122423T1 (el) Παραγωγα πυριμιδινης χρησιμα ως εκλεκτικοι αναστολεις jak3 kai/ή jak1